Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2025-12-24 @ 5:45 PM
NCT ID:
NCT02877368
Eligibility Criteria:
Inclusion Criteria:
* Patients with advanced or high-risk resected gastrointestinal stromal tumours (GIST)
* Patients treated with imatinib prescribed at a fixed dose of 400 mg/day from 1 January 2005 to 31 December 2013
* Aged \> 18 years
Exclusion Criteria:
* Patients who did not have CT imaging within the 30 days preceding treatment onset
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02877368
Study Brief:
Protocol Section:
NCT02877368